• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于小鼠和人类肿瘤中5-氟尿嘧啶耐药机制的研究。

Studies on mechanisms of 5-fluorouracil resistance in murine and human tumors.

作者信息

Ardalan B, Macdonald J S, Cooney D, Schein P S

出版信息

Bull Cancer. 1979;66(1):55-9.

PMID:420947
Abstract

An in vitro cell free assay system to measure phosphorylated products of 5-Fluorouracil is described. Total phosphorylated products and mono-, di and triphosphates of 5-Fluorouracil are measured along with the rate of fluorodeoxyuridylate generation. This assay has been applied to ten murine tumors and eight biopsy specimens from human breast adenocarcinomas. Phosphorylation patterns have been examined in murine tumors demonstrating in vivo sensitivity or resistance to 5-Fluorouracil. There are distinct differences in the patterns of phosphorylation between sensitive and resistant tumors. In a 5-Fluorouracil sensitive murine tumor, mono-, di and triphosphates are produced. In a resistant tumor only monosphophates are produced. Cell free supernatants from human breast tumors produce less total phosphorylation than murine tumors and some specimens produce only monophosphates whereas others produce mono-, di and triphosphates. Human tumors are in general more efficient producers of fluorodeoxyuridylate than murine tumors. These data suggest that resistance to 5-Fluorouracil may correlate with decreased concentration of di and triphosphates of 5-Fluorouracil in some murine tumors. Further experiences is required to demonstrate the value of this easily performed assay system in predicting clinical response to 5-Fluorouracil in man.

摘要

本文描述了一种用于测量5-氟尿嘧啶磷酸化产物的体外无细胞检测系统。该系统可测量5-氟尿嘧啶的总磷酸化产物以及一磷酸、二磷酸和三磷酸产物,同时还能测量氟脱氧尿苷酸的生成速率。此检测方法已应用于十种小鼠肿瘤以及八份来自人乳腺腺癌的活检标本。研究人员对在体内对5-氟尿嘧啶敏感或耐药的小鼠肿瘤的磷酸化模式进行了检测。敏感肿瘤和耐药肿瘤的磷酸化模式存在明显差异。在对5-氟尿嘧啶敏感的小鼠肿瘤中,会产生一磷酸、二磷酸和三磷酸产物。而在耐药肿瘤中,仅产生一磷酸产物。人乳腺肿瘤的无细胞上清液产生的总磷酸化产物比小鼠肿瘤少,一些标本仅产生一磷酸产物,而其他标本则产生一磷酸、二磷酸和三磷酸产物。一般来说,人肿瘤比小鼠肿瘤更有效地产生氟脱氧尿苷酸。这些数据表明,在某些小鼠肿瘤中,对5-氟尿嘧啶的耐药性可能与5-氟尿嘧啶二磷酸和三磷酸浓度降低有关。需要进一步的实验来证明这种易于操作的检测系统在预测人类对5-氟尿嘧啶临床反应方面的价值。

相似文献

1
Studies on mechanisms of 5-fluorouracil resistance in murine and human tumors.关于小鼠和人类肿瘤中5-氟尿嘧啶耐药机制的研究。
Bull Cancer. 1979;66(1):55-9.
2
In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.5-氟尿嘧啶敏感和耐药的小鼠结肠腺癌中胸苷酸合成酶抑制的体内动力学
Cancer Res. 1982 Feb;42(2):450-6.
3
The potential for clinical application of in vitro assays predicting 5-FU sensitivity in man.体外检测预测人体5-氟尿嘧啶敏感性的临床应用潜力。
Cancer Treat Rep. 1981;65 Suppl 3:57-61.
4
Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil.
Cancer Res. 1980 May;40(5):1431-7.
5
Determinants of 5-fluorouracil sensitivity in human tumors.
Bull Cancer. 1979;66(1):79-83.
6
Response-specific adriamycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas.通过体内31P核磁共振波谱法在小鼠乳腺腺癌中提供的针对特定反应的阿霉素敏感性标志物。
Cancer Res. 1987 Jul 1;47(13):3396-401.
7
Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil response.肿瘤5-氟脱氧尿苷酸浓度作为5-氟尿嘧啶反应的决定因素。
Biochem Pharmacol. 1978;27(16):2009-13. doi: 10.1016/0006-2952(78)90059-x.
8
Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.5-氟尿嘧啶后对胸苷酸合成酶抑制的天然抗性机制
Cancer Res. 1988 Oct 15;48(20):5894-900.
9
Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.5-氟尿嘧啶与替加氟的比较。II. 小鼠肿瘤的治疗反应及耐药性发展
Cancer Treat Rep. 1976 Sep;60(9):1347-61.
10
Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil.接受静脉注射5-氟尿嘧啶的患者恶性肿瘤和正常肝脏中胸苷酸合成酶的抑制作用
Cancer Res. 1984 Sep;44(9):4144-50.